| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | NVO | Denmark | $48.02 | $49,580,393,058.00 | Buy | 10 | N/A |
#2 | T | United States | $25.38 | $124,480,000,000.00 | Buy | 21 | N/A |
#3 | VZ | United States | $41.30 | $137,491,000,000.00 | Buy | 12 | 2000 |
#4 | SNY | France | $48.97 | $53,890,648,839.00 | Buy | 4 | N/A |
#5 | BN | Canada | $46.64 | $76,933,000,000.00 | Strong Buy | 7 | N/A |
#6 | CMCSA | United States | $27.20 | $123,311,000,000.00 | Buy | 23 | 1972 |
#7 | NU | Brazil | $17.65 | $6,360,698,000.00 | Buy | 9 | 2021 |
#8 | AMX | Mexico | $21.80 | $51,012,503,011.00 | Buy | 6 | 2001 |
#9 | EPD | United States | $32.60 | $53,004,000,000.00 | Buy | 12 | 1998 |
#10 | FCX | United States | $44.60 | $26,002,000,000.00 | Strong Buy | 16 | N/A |
#11 | CSX | United States | $36.14 | $14,123,000,000.00 | Buy | 22 | N/A |
#12 | TFC | United States | $47.49 | $18,280,000,000.00 | Buy | 13 | N/A |
#13 | KMI | United States | $27.81 | $16,416,000,000.00 | Buy | 13 | 2011 |
#14 | ET | United States | $16.79 | $79,757,000,000.00 | Buy | 13 | 2006 |
#15 | SLB | United States | $38.13 | $35,247,000,000.00 | Strong Buy | 15 | N/A |
#16 | WBD | United States | $24.53 | $37,863,000,000.00 | Buy | 23 | N/A |
#17 | CPNG | United States | $27.00 | $33,664,000,000.00 | Strong Buy | 6 | 2021 |
#18 | JD | China | $29.72 | $183,136,729,092.00 | Buy | 11 | 2014 |
#19 | VALE | Brazil | $13.56 | $40,027,019,862.00 | Buy | 8 | N/A |
#20 | CMG | United States | $34.04 | $11,787,400,000.00 | Buy | 28 | 2006 |
#21 | KVUE | United States | $16.99 | $15,006,000,000.00 | Buy | 13 | 2023 |
#22 | GFI | South Africa | $41.62 | $6,555,200,000.00 | Buy | 8 | 2007 |
#23 | KDP | United States | $28.58 | $16,174,000,000.00 | Buy | 16 | 1993 |
#24 | PCG | United States | $15.32 | $24,762,000,000.00 | Buy | 11 | N/A |
#25 | CUK | United States | $23.77 | $26,230,000,000.00 | Strong Buy | 18 | 2000 |
#26 | CCL | United States | $25.82 | $26,230,000,000.00 | Strong Buy | 18 | 1987 |
#27 | MT | Luxembourg | $42.74 | $61,095,000,000.00 | Buy | 6 | 1997 |
#28 | VICI | United States | $27.96 | $3,969,078,000.00 | Buy | 15 | N/A |
#29 | TEVA | Israel | $28.45 | $16,776,000,000.00 | Strong Buy | 7 | N/A |
#30 | FITB | United States | $45.46 | $8,125,000,000.00 | Buy | 16 | N/A |
#31 | STM | Netherlands | $25.63 | $11,792,000,000.00 | Buy | 8 | 1994 |
#32 | TME | China | $18.71 | $4,455,416,345.00 | Strong Buy | 5 | 2018 |
#33 | HPE | United States | $22.87 | $33,075,000,000.00 | Buy | 18 | N/A |
#34 | KGC | Canada | $27.38 | $6,443,900,000.00 | Strong Buy | 5 | N/A |
#35 | PPL | United States | $34.14 | $8,979,000,000.00 | Buy | 9 | N/A |
#36 | SMCI | United States | $34.20 | $21,052,576,000.00 | Buy | 17 | 2007 |
#37 | HBAN | United States | $17.08 | $7,502,000,000.00 | Buy | 17 | N/A |
#38 | CNP | United States | $38.55 | $9,114,000,000.00 | Buy | 12 | N/A |
#39 | FE | United States | $45.12 | $14,283,000,000.00 | Buy | 14 | N/A |
#40 | HAL | United States | $27.80 | $22,137,000,000.00 | Strong Buy | 16 | N/A |
#41 | DVN | United States | $37.69 | $16,554,000,000.00 | Buy | 21 | N/A |
#42 | GRAB | Singapore | $5.30 | $3,228,000,000.00 | Buy | 4 | N/A |
#43 | RF | United States | $26.41 | $6,945,000,000.00 | Buy | 16 | N/A |
#44 | TTD | United States | $39.32 | $2,790,505,000.00 | Buy | 34 | 2016 |
#45 | TOST | United States | $35.21 | $5,858,000,000.00 | Buy | 22 | 2021 |
#46 | KEY | United States | $19.11 | $5,934,000,000.00 | Buy | 14 | N/A |
#47 | TS | Luxembourg | $41.36 | $11,831,250,000.00 | Buy | 5 | N/A |
#48 | TECK | Canada | $44.87 | $7,526,796,802.00 | Buy | 7 | N/A |
#49 | NTNX | United States | $47.10 | $2,617,547,000.00 | Buy | 16 | 2016 |
#50 | CTRA | United States | $27.35 | $6,666,000,000.00 | Buy | 16 | 1990 |
The FinQuota filters have identified what they believe to be the "Best Blue Chip Stocks Under $50 in December 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.